In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy

In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy

Anna-Maria Ciciliani,1,2 Peter Langguth,1 Herbert Wachtel2 1Institute of Pharmacy and Biochemistry, Faculty 09 (Chemistry, Pharmaceutics and Geosciences), Johannes Gutenberg University, Mainz, 2Analytical Development Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany...

Full description

Bibliographic Details
Main Authors:	Ciciliani A, Langguth P, Wachtel H
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-05-01
Series:	International Journal of COPD
Subjects:	throat model NGI inhalation lung deposition CFD Respimat
Online Access:	https://www.dovepress.com/in-vitro-dose-comparison-of-respimat-inhaler-with-dry-powder-inhalers--peer-reviewed-article-COPD

Similar Items

Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®
by: Dekhuijzen PNR, et al.
Published: (2016-08-01)

A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD
by: Miravitlles M, et al.
Published: (2016-02-01)

Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations
by: Tan CK, et al.
Published: (2016-09-01)

In-vitro inhalation performance for formoterol dry powder and metred dose inhalers. In-vitro characteristics of the emitted dose from the formoterol dry powder and metred dose inhalers to identify the influence of inhalation flow, inhalation volume and the number of inhalation per dose.
by: Alaboud, S.
Published: (2013)

Investigations to identify the influence of the inhalation manoeuvre on the ex-vivo dose emission and the in-vitro aerodynamic dose emission characteristics of dry powder inhalers: Studies to identify the influence of inhalation flow, inhalation volume and the number of inhalations per dose on the ex-vivo dose emission and the in-vitro aerodynamic dose emission characteristics of dry powder inhalers.
by: Ibn Yakubu, Sani
Published: (2011)

Development of clinically relevant in vitro performance tests for powder inhalers
by: Wei, Xiangyin
Published: (2015)

Patients’ usability of seven most used dry-powder inhalers in COPD
by: Roberto W. Dal Negro, et al.
Published: (2019-09-01)

October 2013 Tucson pulmonary journal club: tiotropium Respimat
by: Eddib A, et al.
Published: (2013-11-01)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
by: Imco Sibum, et al.
Published: (2019-05-01)

Particle interactions in dry powder inhalations
by: Lord, John David
Published: (1993)

Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers
by: Wittbrodt ET, et al.
Published: (2018-12-01)

Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?
by: Masato Muraki, et al.
Published: (2017-01-01)

An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation
by: Xuemei Zhang, et al.
Published: (2014-02-01)

Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler
by: Dhand R, et al.
Published: (2019-03-01)

The Use of Video Instructions in Patient Education Promoting Correct Technique for Dry Powder Inhalers: An Investigation on Inhaler-Naïve Individuals
by: Sofia von Schantz, et al.
Published: (2018-09-01)

Clinical and economic evaluation of using fixed dose dual bronchodilator combination tiotropiumolodaterol in patients with chronic obstructive pulmonary disease
by: S. K. Zyryanov, et al.
Published: (2018-04-01)

Preference for Easyhaler® Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study
by: Alvarez-Gutiérrez FJ, et al.
Published: (2021-02-01)

Flow and Particle Modelling of Dry Powder Inhalers: Methodologies, Recent Development and Emerging Applications
by: Zhanying Zheng, et al.
Published: (2021-02-01)

Inhaler treatment options in COPD
by: S. P. Newman
Published: (2005-12-01)

Numerical and Experimental Investigation on Key Parameters of the Respimat<sup>®</sup> Spray Inhaler
by: Yi Ge, et al.
Published: (2021-12-01)

ASTHMA AND THE INHALATION TECHNIQUE FOR THE PRESSURIZED METERED-DOSE INHALER WITH SPACER: AN INTEGRATIVE REVIEW
by: Isabela Cristine Ferreira Fernandes, et al.
Published: (2019-07-01)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
by: Jose R. Jardim, et al.
Published: (2019-04-01)

Critical characteristics for corticosteroid solution metered dose inhaler bioequivalence
by: Grainger, C.I., et al.
Published: (2019)

Inhalation devices in COPD Management
by: Romaniuk Verge, Kathy
Published: (2011)

In vitro Evaluation of Dry Powder Inhaler Devices of Corticosteroid Preparations
by: Gen Tamura, et al.
Published: (2012-01-01)

Dry Powder Inhalers in the Digitalization Era: Current Status and Future Perspectives
by: Styliani Xiroudaki, et al.
Published: (2021-09-01)

COPD: misuse of inhaler devices in clinical practice
by: Duarte-de-Araújo A, et al.
Published: (2019-05-01)

Dry powder inhalers: Particle size and patient-satisfaction
by: S K Jindal, et al.
Published: (2021-01-01)

Three-dimensional DEM–CFD analysis of air-flow-induced detachment of API particles from carrier particles in dry powder inhalers
by: Jiecheng Yang, et al.
Published: (2014-02-01)

Inhaler choice in primary practice
by: K. R. Chapman, et al.
Published: (2005-12-01)

Excipient-API interactions in dry powder inhalers
by: Shireesh Apte
Published: (2012-12-01)

Studies on the spray dried lactose as carrier for dry powder inhalation
by: Linna Wu, et al.
Published: (2014-12-01)

Performance of two different types of inhalers. Influence of flow and spacer on emitted dose and aerodynamic characterisation.
by: Almeziny, Mohammed A.N.
Published: (2010)

Physicochemical and Aerosolization Assessment of Inhalable Spray Dried Fluconazole Powder
by: Hamed Hamishehkar, et al.
Published: (2018-09-01)

Characterization of Inhalable Aerosols from Cosmetic Powders and Sustainability in Cosmetic Products
by: Hyeon-Ju Oh, et al.
Published: (2020-10-01)

Acute cardiopulmonary repercussions in the correct use of the dry-powder inhalers
by: Bruno Martinelli, et al.
Published: (2016-02-01)

The influence of amino acids on aztreonam spray-dried powders for inhalation
by: Xiao-Fei Yang, et al.
Published: (2015-12-01)

Lactose Engineering for Better Performance in Dry Powder Inhalers
by: Yahya Rahimpour, et al.
Published: (2012-08-01)

A Quality by Design Framework for Capsule-Based Dry Powder Inhalers
by: Li Ding, et al.
Published: (2021-08-01)

Adhesive mixtures for dry powder inhalation
by: Lagercrantz Forss, Louise
Published: (2021)